Danaher Corporation $DHR Stock Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. lessened its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 8.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 969,088 shares of the conglomerate's stock after selling 94,068 shares during the quarter. Russell Investments Group Ltd. owned about 0.14% of Danaher worth $215,064,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in DHR. Eurizon Capital SGR S.p.A. raised its position in shares of Danaher by 16.8% in the third quarter. Eurizon Capital SGR S.p.A. now owns 284,412 shares of the conglomerate's stock valued at $63,120,000 after purchasing an additional 41,003 shares during the period. Nan Fung Trinity HK Ltd. lifted its stake in shares of Danaher by 150.5% in the third quarter. Nan Fung Trinity HK Ltd. now owns 171,200 shares of the conglomerate's stock worth $37,929,000 after buying an additional 102,865 shares during the last quarter. Van Strum & Towne Inc. bought a new stake in shares of Danaher during the 3rd quarter worth $217,000. Three Bridge Wealth Advisors LLC bought a new stake in shares of Danaher during the 3rd quarter worth $55,000. Finally, Schwallier Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter worth $229,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Down 1.4%

Shares of DHR stock opened at $232.08 on Friday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The firm has a market cap of $163.28 billion, a PE ratio of 37.98, a price-to-earnings-growth ratio of 2.95 and a beta of 0.76. The stock has a 50 day moving average of $222.11 and a 200-day moving average of $201.53.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The business had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same quarter last year, the company posted $1.89 earnings per share. Danaher's quarterly revenue was up 8.3% on a year-over-year basis. On average, equities analysts predict that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were issued a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher's dividend payout ratio is 26.19%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Morgan Stanley raised their target price on shares of Danaher from $220.00 to $240.00 and gave the company an "overweight" rating in a research note on Monday, October 12th. The Goldman Sachs Group reissued a "buy" rating and set a $275.00 target price on shares of Danaher in a research report on Thursday, October 22nd. Citigroup upped their price target on shares of Danaher from $230.00 to $270.00 and gave the company a "buy" rating in a report on Thursday, October 22nd. Guggenheim raised their price target on Danaher from $200.00 to $250.00 and gave the company a "buy" rating in a research report on Thursday, October 1st. Finally, DZ Bank lowered Danaher from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, October 27th. Eighteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $242.91.

Insider Buying and Selling at Danaher

In other Danaher news, CAO Christopher Bouda sold 7,598 shares of the firm's stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total value of $1,782,186.88. Following the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. This trade represents a 45.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Gregory Milosevich sold 2,100 shares of the business's stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $230.62, for a total transaction of $484,302.00. Following the transaction, the executive vice president owned 22,367 shares in the company, valued at approximately $5,158,277.54. The trade was a 8.58% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 10.80% of the company's stock.

Danaher Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company's businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.